Advanced company searchLink opens in new window

CARDIOGENI PLC

Company number 10541091

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 Feb 2025 SH01 Statement of capital following an allotment of shares on 31 January 2025
  • GBP 83,004.66
11 Feb 2025 AP01 Appointment of Professor Joanne Elizabeth Martin as a director on 31 January 2025
03 Feb 2025 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES14 ‐ Re: directors authorised to capitalise a sum not exceeding £2,806,885 standing to the credit of the company's merger reserve / to apply such sum in paying up in new ordinary shares of £0.01 each in the capital of the company up to an aggregate nominal amount of £2,806,885 (bonus shares) 12/12/2024
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
06 Jan 2025 RESOLUTIONS Resolutions
  • RES02 ‐ Resolution of re-registration
06 Jan 2025 BS Balance Sheet
06 Jan 2025 AUDS Auditor's statement
06 Jan 2025 AUDR Auditor's report
06 Jan 2025 MAR Re-registration of Memorandum and Articles
06 Jan 2025 CERT7 Certificate of change of name and re-registration from Private to Public Limited Company
06 Jan 2025 RR01 Re-registration from a private company to a public company
06 Jan 2025 CERTNM Company name changed celixir LIMITED\certificate issued on 06/01/25
  • CONNOT ‐ Change of name notice
23 Dec 2024 SH01 Statement of capital following an allotment of shares on 12 December 2024
  • GBP 830,046.6
23 Dec 2024 SH01 Statement of capital following an allotment of shares on 12 December 2024
  • GBP 83,004.66
23 Dec 2024 SH08 Change of share class name or designation
19 Dec 2024 AA Group of companies' accounts made up to 31 March 2024
17 Dec 2024 SH01 Statement of capital following an allotment of shares on 7 November 2024
  • GBP 69,399.39
03 Nov 2024 MA Memorandum and Articles of Association
30 Oct 2024 SH19 Statement of capital on 30 October 2024
  • GBP 68,119.39
30 Oct 2024 SH20 Statement by Directors
30 Oct 2024 CAP-SS Solvency Statement dated 21/10/24
30 Oct 2024 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 24/10/2024
  • RES14 ‐ Capitalise up to £4087163.40 from merger reserve 24/10/2024
  • RES10 ‐ Resolution of allotment of securities
  • RES06 ‐ Resolution of reduction in issued share capital
  • RES01 ‐ Resolution of adoption of Articles of Association
29 Oct 2024 SH01 Statement of capital following an allotment of shares on 29 October 2024
  • GBP 4,155,282.79
29 Oct 2024 SH19 Statement of capital on 29 October 2024
  • GBP 68,119.39
29 Oct 2024 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES13 ‐ Reduce share premium 24/10/2024
  • RES14 ‐ Capitalise £4,087,163.40 24/10/2024
29 Oct 2024 CAP-SS Solvency Statement dated 21/10/24